-
Recombinant Mononucleosomes H3.3 (K4M)
Recombinant Mononucleosomes H3.3 (K4M)
- 中文名称：
- Recombinant Mononucleosomes H3.3 (K4M)
- 英文名称：
- Recombinant Mononucleosomes H3.3 (K4M)
- 品牌：
- AAA Biotech
- 品牌介绍：
- AAA Biotech专注于为全球生命科学研究提供高品质的蛋白质研究工具，核心产品包括经严格验证的抗体、重组蛋白及ELISA试剂盒。
- 货号：
- AAA60228
- 规格：
- 0.02 mg|1 mg|2x1 mg|3x1 mg|4x1 mg
- 保存建议：
- Recombinant proteins in solution are temperature sensitive and must be stored at -80 degree C to prevent degradation. Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
Shipping Temp: Dry Ice
- 货期：
- 6-8周
- 纯度：
- N/A
- 产品形式：
- Recombinant Mononucleosomes H3.3 (K4M)(20ug protein + 20ug DNA) is supplied in 10mM Tris-HCl pH8.0, 1mM EDTA, 2mM DTT, and 20% glycerol.
- 免责声明：
- *本产品仅供科研实验使用，不得用于临床诊断。*
- 说明书：
Background: Recombinant nucleosomes are widely used in histone methyltransferase screening assays to identify small molecular inhibitors for drug discovery. Histone H3.1 and Histone H3.3 are the two main Histone H3 variants found in plants and animals and are known to be important for gene regulation. Histone H3.1 and H3.3 demonstrate unique genomic localization patterns thought to be associated with their specific functions in regulation of gene activity. Specifically, Histone H3.3 primarily co-localizes with marks associated with gene activation (H3K4me3, H2BK120ub1, and RNA pol II occupancy). Deposition of the Histone H3.1 variant into the nucleosome correlates with the canonical DNA synthesis-dependent deposition pathway, whereas Histone H3.3 primarily serves as the replacement Histone H3 variant outside of S-phase, such as during gene transcription. Histones are linked to tumorigenesis primarily through alterations in their PTMs and the enzymes regulating these modifications, suggesting that they might disrupt the reading, writing, and/or erasing of these marks. Except for being near K9, which can be methylated or acetylated, R8 site itself can be methylated too. Mutations in histone H3 occur with high genetic penetrance within rare gliomas and sarcomas. Researchers have found that histones containing mutations at H3 N-terminal residues at or near PTM sites including R2, R8, K18 and R26 may be considered as oncogenic.
